[ad_1]
Hearken to this text
Automata’s collaborative robotic arm Eva. | Supply: Automata
Automata, an organization centered on life sciences automation, raised $50 million in Sequence B funding. The corporate plans to make use of the financing to additional develop its lab automation platform, Automata Labs, to be used in and out of doors of the UK.
Automata Labs was created to make scaling up straightforward for diagnostics labs, drug discovery labs and extra. The corporate claims its system will be applied inside weeks and may automate every stage of workflow. It additionally provides a versatile robotic arm known as Eva. Eva has six levels of freedom and was designed to work on exact and repeatable duties. It has a lower than 3 lb payload (1.25 kg).
Octopus Ventures led the financing spherical. Present traders, like Hummingbird, Latitude Ventures, ABB Expertise Ventures and Osomer Capital additionally participated. The spherical additionally included strategic traders, like In-Q-Tel.
“Automata Labs accelerates human ingenuity, empowering labs and scientists to realize constant outcomes quicker, on a better scale, and to finally upscale their ambitions,” Jess McCreadie, principal at Octopus Ventures, mentioned. “We’re delighted to have led this financing spherical as Automata represented precisely the kind of extremely progressive firm we put money into and assist. We’re excited for Automata’s subsequent steps, each inside the life sciences business, and past.”
Automata started in 2015, and it was based by Mostafa ElSayed and Suryansh Chandra, two architects from Zaha Hadid’s analysis lab. The corporate’s objective is to allow new alternatives for innovation with automation.
“For much too lengthy scientists and clinicians have been having to work with overly complicated lab options whereby the tools and software program are disjointed and tough to orchestrate,” ElSayed, now the corporate’s CEO, mentioned. “Options are additionally usually too inflexible and inappropriate for labs with small geographic footprints. Our subsequent era know-how solves this.”
To this point, the corporate has raised a complete of $59.5 million in financing. The corporate is predicated in London.
[ad_2]